{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:06:43Z","timestamp":1790802403280,"version":"4.1.0"},"reference-count":178,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Ascorbic acid has attracted substantial attention for its potential antitumor effects by acting as an antioxidant\n                    <jats:italic>in vivo<\/jats:italic>\n                    and as a cofactor in diverse enzymatic reactions. However, solid proof of its clinical efficacy against cancer and the mechanism behind its effect have not been established. Moreover, cancer forms cancer-specific microenvironments and interacts with various cells, such as cancer-associated fibroblasts (CAFs), to maintain cancer growth and progression; however, the effect of ascorbic acid on the cancer microenvironment is unclear. This review discusses the effects and mechanisms of ascorbic acid on cancer, including the role of ascorbic acid concentration. In addition, we present future perspectives on the effects of ascorbic acid on cancer cells and the CAF microenvironment. Ascorbic acid has a variety of effects, which contributes to the complexity of these effects. Oral administration of ascorbic acid results in low blood concentrations (&amp;lt;0.2 mM) and acts as a cofactor for antioxidant effects, collagen secretion, and HIF\u03b1 degradation. In contrast, intravenous treatment achieves large blood concentrations (&amp;gt;1 mM) and has oxidative-promoting actions that exert anticancer effects\n                    <jats:italic>via<\/jats:italic>\n                    reactive oxygen species. Therefore, intravenous administration at high concentrations is required to achieve the desired effects on cancer cells during treatment. Partial data on the effect of ascorbic acid on fibroblasts indicate that it may also modulate collagen secretion in CAFs and impart tumor-suppressive effects. Thus, future studies should verify the effect of ascorbic acid on CAFs. The findings of this review can be used to guide further research and clinical trials.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2022.981547","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T06:14:34Z","timestamp":1663654474000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Diverse antitumor effects of ascorbic acid on cancer cells and the tumor microenvironment"],"prefix":"10.3389","volume":"12","author":[{"given":"Takeru","family":"Maekawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaji","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Uemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(88)90093-8","article-title":"Occurrence in humans and guinea pigs of the gene related to their missing enzyme l-gulono-gamma-lactone oxidase","volume":"267","author":"Nishikimi","year":"1988","journal-title":"Arch Biochem Biophys"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/odi.12446","article-title":"[Vitamin c]","volume":"97","author":"Vald\u00e9s","year":"2006","journal-title":"Actas Dermo Sifiliogr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/07315724.2003.10719272","article-title":"Vitamin c as an antioxidant: evaluation of its role in disease prevention","volume":"22","author":"Padayatty","year":"2003","journal-title":"J Am Coll Nutr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/54.6.1135s","article-title":"Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy","volume":"54","author":"Peterkofsky","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10121894","article-title":"The role of vitamin c in cancer prevention and therapy: A literature review","volume":"10","author":"Villagran","year":"2021","journal-title":"Antioxid (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13046-021-02134-y","article-title":"High-dose intravenous vitamin c, a promising multi-targeting agent in the treatment of cancer","volume":"40","author":"B\u00f6ttger","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature19084","article-title":"Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion","volume":"536","author":"Sousa","year":"2016","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0959","article-title":"Selective alanine transporter utilization creates a targetable metabolic niche in pancreatic cancer","volume":"10","author":"Parker","year":"2020","journal-title":"Cancer Discov"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25636","article-title":"Fibrosis in metastatic lymph nodes is clinically correlated to poor prognosis in colorectal cancer","volume":"9","author":"Ikuta","year":"2018","journal-title":"Oncotarget"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07891-x","article-title":"Vimentin expression in tumor microenvironment predicts survival in pancreatic ductal adenocarcinoma: heterogeneity in the fibroblast population","volume":"26","author":"Maehira","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-0454","article-title":"Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis","volume":"79","author":"Mizutani","year":"2019","journal-title":"Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/odi.12446","article-title":"Vitamin c physiology: the known and the unknown and goldilocks","volume":"22","author":"Padayatty","year":"2016","journal-title":"Oral Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/19986","article-title":"A family of mammalian na+-dependent l-ascorbic acid transporters","volume":"399","author":"Tsukaguchi","year":"1999","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1929","article-title":"Human vitamin c (L-ascorbic acid) transporter SVCT1","volume":"267","author":"Wang","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ars.2020.8166","article-title":"Transport of vitamin c in cancer","volume":"35","author":"Mu\u00f1oz-Montesino","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0702854104","article-title":"Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo","volume":"104","author":"Chen","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.8.3704","article-title":"Vitamin c pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance","volume":"93","author":"Levine","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-7-200404060-00010","article-title":"Vitamin c pharmacokinetics: implications for oral and intravenous use","volume":"140","author":"Padayatty","year":"2004","journal-title":"Ann Intern Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-013-2179-9","article-title":"Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer","volume":"72","author":"Stephenson","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12323","article-title":"Elimination of ascorbic acid after high-dose infusion in prostate cancer patients: A pharmacokinetic evaluation","volume":"116","author":"Nielsen","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn377","article-title":"Phase I clinical trial of i.v. ascorbic acid in advanced malignancy","volume":"19","author":"Hoffer","year":"2008","journal-title":"Ann Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5202606","article-title":"Effect of high-dose vitamin c infusion in a glucose-6-Phosphate dehydrogenase-deficient patient","volume":"2017","author":"Quinn","year":"2017","journal-title":"Case Rep Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029794","article-title":"Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer","volume":"7","author":"Monti","year":"2012","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120228","article-title":"High-dose intravenous vitamin c combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial","volume":"10","author":"Hoffer","year":"2015","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/antiox7070089","article-title":"Systematic review of intravenous ascorbate in cancer clinical trials","volume":"7","author":"Nauman","year":"2018","journal-title":"Antioxid (Basel)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2012.06.003","article-title":"Ascorbic acid: chemistry, biology and the treatment of cancer","volume":"1826","author":"Du","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051501","article-title":"Two faces of vitamin c-antioxidative and pro-oxidative agent","volume":"12","author":"Ka\u017amierczak-Bara\u0144ska","year":"2020","journal-title":"Nutrients"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.931844","article-title":"Some current insights into oxidative stress","volume":"59","author":"\u010eura\u010dkov\u00e1","year":"2010","journal-title":"Physiol Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-021-04994-9","article-title":"Essential features for antioxidant capacity of ascorbic acid (vitamin c)","volume":"28","author":"Santos","year":"2021","journal-title":"J Mol Model"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/74.3.402","article-title":"Antioxidant vitamin status and carotid atherosclerosis in the elderly","volume":"74","author":"Gale","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804226105","article-title":"Pharmacologic doses of ascorbate act as a pro-oxidant and decrease growth of aggressive tumor xenografts in mice","volume":"105","author":"Chen","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7286737","article-title":"Pro- and antioxidant effects of vitamin c in cancer in correspondence to its dietary and pharmacological concentrations","volume":"2019","author":"Pawlowska","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio863","article-title":"Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one","volume":"3","author":"Ozer","year":"2007","journal-title":"Nat Chem Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.6.1173","article-title":"Characterization of the iron- and 2-oxoglutarate-binding sites of human prolyl 4-hydroxylase","volume":"16","author":"Myllyharju","year":"1997","journal-title":"EMBO J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192342099","article-title":"Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor","volume":"99","author":"Ivan","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200273200","article-title":"Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family","volume":"277","author":"Hewitson","year":"2002","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/gad.991402","article-title":"FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor","volume":"16","author":"Lando","year":"2002","journal-title":"Genes Dev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2407223","article-title":"Regulation of transactivation at c-TAD domain of HIF-1 alpha by factor-inhibiting HIF-1 alpha (FIH-1): A potential target for therapeutic intervention in cancer","volume":"2022","author":"Rani","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von hippel-lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-alpha binding and ubiquitylation by the von hippel-lindau tumor suppressor protein","volume":"275","author":"Cockman","year":"2000","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2014.01.033","article-title":"Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response","volume":"69","author":"Kuiper","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102412","article-title":"The pharmacokinetics of vitamin c","volume":"11","author":"Lykkesfeldt","year":"2019","journal-title":"Nutrients"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2145-x","article-title":"The epigenetic role of vitamin c in health and disease","volume":"73","author":"Camarena","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nature12362","article-title":"Vitamin c induces tet-dependent DNA demethylation and a blastocyst-like state in ES cells","volume":"500","author":"Blaschke","year":"2013","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12080","article-title":"Effects of alkalization therapy on chemotherapy outcomes in advanced pancreatic cancer: A retrospective case-control study","volume":"34","author":"Hamaguchi","year":"2020","journal-title":"In Vivo"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/nu11050977","article-title":"The effect of vitamin c (ascorbic acid) in the treatment of patients with cancer: A systematic review","volume":"11","author":"van Gorkom","year":"2019","journal-title":"Nutrients"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.11.110","article-title":"Ascorbic acid enhances the expression of type 1 and type 4 collagen and SVCT2 in cultured human skin fibroblasts","volume":"430","author":"Kishimoto","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(95)00640-0","article-title":"Ascorbic acid preferentially enhances type I and III collagen gene transcription in human skin fibroblasts","volume":"11","author":"Tajima","year":"1996","journal-title":"J Dermatol Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41598-018-36682-9","article-title":"Ascorbic acid encapsulated into negatively charged liposomes exhibits increased skin permeation, retention and enhances collagen synthesis by fibroblasts","volume":"9","author":"Maione-Silva","year":"2019","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12393187","article-title":"Effects of ascorbic acid on proliferation and collagen synthesis in relation to the donor age of human dermal fibroblasts","volume":"103","author":"Phillips","year":"1994","journal-title":"J Invest Dermatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1177\/153303460900800309","article-title":"Effect of siRNA targeting HIF-1alpha combined l-ascorbate on biological behavior of hypoxic MiaPaCa2 cells","volume":"8","author":"Chen","year":"2009","journal-title":"Technol Cancer Res Treat"},{"key":"B58","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13148-016-0213-6","article-title":"Vitamin c enhances epigenetic modifications induced by 5-azacytidine and cell cycle arrest in the hepatocellular carcinoma cell lines HLE and Huh7","volume":"8","author":"Sajadian","year":"2016","journal-title":"Clin Epigenet"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S222702","article-title":"High-dose vitamin c suppresses the invasion and metastasis of breast cancer cells via inhibiting epithelial-mesenchymal transition","volume":"12","author":"Zeng","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/leu.2017.171","article-title":"Vitamin c-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia","volume":"32","author":"Mingay","year":"2018","journal-title":"Leukemia"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.07.033","article-title":"Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma","volume":"150","author":"Lian","year":"2012","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1038\/s41598-017-03893-5","article-title":"Ascorbate induces apoptosis in melanoma cells by suppressing clusterin expression","volume":"7","author":"Mustafi","year":"2017","journal-title":"Sci Rep"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2019.1666652","article-title":"Vitamin c in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells","volume":"15","author":"Gerecke","year":"2020","journal-title":"Epigenetics"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/antiox7030041","article-title":"Influence of vitamin c on lymphocytes: an overview","volume":"7","author":"van Gorkom","year":"2018","journal-title":"Antioxid (Basel)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1042\/BST20180169","article-title":"Vitamin c and immune cell function in inflammation and cancer","volume":"46","author":"Ang","year":"2018","journal-title":"Biochem Soc Trans"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.03416","article-title":"Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4+ T cells tolerated by peptide immunotherapy","volume":"3","author":"McPherson","year":"2014","journal-title":"Elife"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C113.464800","article-title":"Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine","volume":"288","author":"Minor","year":"2013","journal-title":"J Biol Chem"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)01638-0","article-title":"Estimation of H2O2 gradients across biomembranes","volume":"475","author":"Antunes","year":"2000","journal-title":"FEBS Lett"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1909","article-title":"Relationship between 18F-fluorodeoxyglucose accumulation and KRAS\/BRAF mutations in colorectal cancer","volume":"18","author":"Kawada","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1126\/science.1174229","article-title":"Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells","volume":"325","author":"Yun","year":"2009","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/mmr.2011.736","article-title":"Overexpression of GLUT1 correlates with kras mutations in lung carcinomas","volume":"5","author":"Sasaki","year":"2012","journal-title":"Mol Med Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tibs.2013.12.004","article-title":"KRAS: feeding pancreatic cancer proliferation","volume":"39","author":"Bryant","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5552-09.2010","article-title":"NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death","volume":"30","author":"Alano","year":"2010","journal-title":"J Neurosci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa5004","article-title":"Vitamin c selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH","volume":"350","author":"Yun","year":"2015","journal-title":"Science"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20090854","article-title":"Oxidative modifications of glyceraldehyde-3-phosphate dehydrogenase play a key role in its multiple cellular functions","volume":"423","author":"Hwang","year":"2009","journal-title":"Biochem J"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0135-7","article-title":"Targeting cancer vulnerabilities with high-dose vitamin c","volume":"19","author":"Ngo","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.2001.280.3.C659","article-title":"Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells","volume":"280","author":"Brar","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6816214","article-title":"ROS pleiotropy in melanoma and local therapy with physical modalities","volume":"2021","author":"Sagwal","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0631","article-title":"Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress","volume":"11","author":"Baldi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22654","article-title":"Vitamin c at high concentrations induces cytotoxicity in malignant melanoma but promotes tumor growth at low concentrations","volume":"56","author":"Yang","year":"2017","journal-title":"Mol Carcinog"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.20455\/ros.2020.833","article-title":"Fe2+ as a physiological and selective inhibitor of vitamin c-induced cancer cell death","volume":"10","author":"Murayama","year":"2020","journal-title":"React Oxygen Species"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1713","article-title":"Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer","volume":"16","author":"Du","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00010","article-title":"Increased tumor ascorbate is associated with extended disease-free survival and decreased hypoxia-inducible factor-1 activation in human colorectal cancer","volume":"4","author":"Kuiper","year":"2014","journal-title":"Front Oncol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2887","article-title":"Hypoxia-inducible factor-1A promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts","volume":"66","author":"Dang","year":"2006","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","article-title":"MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer","volume":"32","author":"Shukla","year":"2017","journal-title":"Cancer Cell"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.2018","article-title":"Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic\/molecular profile of tumours and survival","volume":"85","author":"Giatromanolaki","year":"2001","journal-title":"Br J Cancer"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"key":"B88","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12935-020-01370-0","article-title":"Implications of HIF-1\u03b1 in the tumorigenesis and progression of pancreatic cancer","volume":"20","author":"Jin","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67230","article-title":"HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations","volume":"123","author":"Semenza","year":"2013","journal-title":"J Clin Invest"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0263","article-title":"Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer","volume":"70","author":"Kuiper","year":"2010","journal-title":"Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.08.027","article-title":"Pharmacokinetic and anticancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice","volume":"99","author":"Campbell","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.08.004","article-title":"HIF-dependent antitumorigenic effect of antioxidants in vivo","volume":"12","author":"Gao","year":"2007","journal-title":"Cancer Cell"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00128","article-title":"Reprogramming the epigenome with vitamin c","volume":"7","author":"Lee Chong","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2015.01.001","article-title":"5-hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer","volume":"1855","author":"Kroeze","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1515\/bmc-2014-0010","article-title":"The jumonji family: past, present and future of histone demethylases in cancer","volume":"5","author":"Franci","year":"2014","journal-title":"Biomol Concepts"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/nature10866","article-title":"IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype","volume":"483","author":"Turcan","year":"2012","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/nature04433","article-title":"Histone demethylation by a family of JmjC domain-containing proteins","volume":"439","author":"Tsukada","year":"2006","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","first-page":"17188","DOI":"10.1038\/s41598-017-17568-8","article-title":"High dose parenteral ascorbate inhibited pancreatic cancer growth and metastasis: mechanisms and a phase I\/IIa study","volume":"7","author":"Polireddy","year":"2017","journal-title":"Sci Rep"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00819","article-title":"Role of vitamin c in skin diseases","volume":"9","author":"Wang","year":"2018","journal-title":"Front Physiol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1046\/j.1467-2494.1998.171747.x","article-title":"Effect of vitamin c and its derivatives on collagen synthesis and cross-linking by normal human fibroblasts","volume":"20","author":"Boyera","year":"1998","journal-title":"Int J Cosmet Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/ma14051211","article-title":"Highly porous and superabsorbent biomaterial made of marine-derived polysaccharides and ascorbic acid as an optimal dressing for exuding wound management","volume":"14","author":"Vivcharenko","year":"2021","journal-title":"Mater (Basel)"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12339344","article-title":"Antioxidant nutrients protect against UVB-induced oxidative damage to DNA of mouse keratinocytes in culture","volume":"106","author":"Stewart","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-007-0804-3","article-title":"Visualization and characterization of UVB-induced reactive oxygen species in a human skin equivalent model","volume":"300","author":"Hakozaki","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1021\/bi0263210","article-title":"Vitamin c suppresses TNF alpha-induced NF-kappaB activation by inhibiting I kappa b alpha","volume":"41","author":"C\u00e1rcamo","year":"2002","journal-title":"Biochemistry"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2005.31725","article-title":"Topical vitamin c: a useful agent for treating photoaging and other dermatologic conditions","volume":"31","author":"Farris","year":"2005","journal-title":"Dermatol Surg"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.53.2.335","article-title":"Enzymatic hydroxylation of proline in microsomal polypeptide leading to formation of collagen","volume":"53","author":"Peterkofsky","year":"1965","journal-title":"Proc Natl Acad Sci USA"},{"key":"B107","article-title":"Regulation of collagen biosynthesis by ascorbic acid: a review","volume":"58","author":"Pinnell","year":"1985","journal-title":"Yale J Biol Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.116.138594","article-title":"Vitamin c-enriched gelatin supplementation before intermittent activity augments collagen synthesis","volume":"105","author":"Shaw","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13324","article-title":"Ascorbic acid promotes a TGF\u03b21-induced myofibroblast phenotype switch","volume":"5","author":"Piersma","year":"2017","journal-title":"Physiol Rep"},{"key":"B110","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3892\/ijo.2012.1712","article-title":"Ascorbate supplementation inhibits growth and metastasis of B1 6FO melanoma and 4T1","volume":"42","author":"Cha","year":"2013","journal-title":"Int J Oncol"},{"key":"B111","article-title":"Anticytoproliferative effect of vitamin c on rat hepatic stellate cells","volume":"8","author":"Su","year":"2016","journal-title":"Am J Transl Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205535","article-title":"Beneficial effects of ascorbic acid to treat lung fibrosis induced by paraquat","volume":"13","author":"Rodrigues da Silva","year":"2018","journal-title":"PLoS One"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.73.10.3685","article-title":"Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer","volume":"73","author":"Cameron","year":"1976","journal-title":"Proc Natl Acad Sci USA"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.9.4538","article-title":"Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer","volume":"75","author":"Cameron","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197909273011303","article-title":"Failure of high-dose vitamin c (ascorbic acid) therapy to benefit patients with advanced cancer. a controlled trial","volume":"301","author":"Creagan","year":"1979","journal-title":"N Engl J Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198501173120301","article-title":"High-dose vitamin c versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. a randomized double-blind comparison","volume":"312","author":"Moertel","year":"1985","journal-title":"N Engl J Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061879","article-title":"Patients undergoing myeloablative chemotherapy and hematopoietic stem cell transplantation exhibit depleted vitamin c status in association with febrile neutropenia","volume":"12","author":"Carr","year":"2020","journal-title":"Nutrients"},{"key":"B118","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1191\/0269216305pm970oa","article-title":"Vitamin c deficiency in cancer patients","volume":"19","author":"Mayland","year":"2005","journal-title":"Palliat Med"},{"key":"B119","unstructured":"Intravenous vitamin c in combination with standard chemotherapy for pancreatic cancer"},{"key":"B120","unstructured":"Arsenic trioxide plus vitamin c in treating patients with recurrent or refractory multiple myeloma2003"},{"key":"B121","article-title":"Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed\/refractory multiple myeloma","volume":"8","author":"Bahlis","year":"2002","journal-title":"Clin Cancer Res"},{"key":"B122","volume-title":"Bortezomib, ascorbic acid, and melphalan in treating patients with newly diagnosed multiple myeloma","year":"2006"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2009.01244.x","article-title":"Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen","volume":"82","author":"Berenson","year":"2009","journal-title":"Eur J Haematol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-013-2070-8","article-title":"Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial","volume":"71","author":"Welsh","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"B125","volume-title":"A research trial of high dose vitamin c and chemotherapy for metastatic pancreatic cancer","year":"2015"},{"key":"B126","volume-title":"Trial of chemotherapy plus intravenous vitamin c in patients with advanced cancer for whom chemotherapy alone is only marginally effective","year":"2010"},{"key":"B127","volume-title":"Vitamin c as an anti-cancer drug","year":"2010"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2017.04.42","article-title":"Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: a single-arm phase II trial","volume":"6","author":"Nielsen","year":"2017","journal-title":"Transl Androl Urol"},{"key":"B129","volume-title":"New treatment option for pancreatic cancer","year":"2011"},{"key":"B130","volume-title":"Treatment of newly diagnosed ovarian cancer with antioxidants","year":"2005"},{"key":"B131","doi-asserted-by":"publisher","first-page":"222ra18","DOI":"10.1126\/scitranslmed.3007154","article-title":"High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy","volume":"6","author":"Ma","year":"2014","journal-title":"Sci Transl Med"},{"key":"B132","volume-title":"Safety and efficacy of vitamin c infusion in combination with local mEHT to treat non small cell lung cancer","year":"2016"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2020.03.004","article-title":"A randomized phase II trial of best supportive care with or without hyperthermia and vitamin c for heavily pretreated, advanced, refractory non-small-cell lung cancer","volume":"24","author":"Ou","year":"2020","journal-title":"J Adv Res"},{"key":"B134","volume-title":"Ph 2 trial of vitamin c & G-FLIP (Low doses gemcitabine, 5FU, leucovorin, irinotecan, oxaliplatin) for pancreatic cancer","year":"2013"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.e15711","article-title":"Broad safety impact of high-dose ascorbic acid and induction chemotherapy for high-risk pancreatic cancer","volume":"35","author":"Bruckner","year":"2017","journal-title":"J Clin Oncol"},{"key":"B136","volume-title":"A study of vitamin c in the treatment of liver cancer to determine if it is safe and effective","year":"2012"},{"key":"B137","volume-title":"Trial of ascorbic acid (AA) + nanoparticle paclitaxel protein bound + cisplatin + gemcitabine (AA NABPLAGEM)","year":"2018"},{"key":"B138","volume-title":"Effect of vitamin c in autologous stem cell transplantations","year":"2019"},{"key":"B139","volume-title":"A phase 2 trial of high-dose ascorbate for pancreatic cancer (PACMAN 2.1)","year":"2016"},{"key":"B140","volume-title":"High dose vitamin c intravenous infusion in patients with resectable or metastatic solid tumor malignancies","year":"2017"},{"key":"B141","volume-title":"Ascorbic acid and combination chemotherapy for the treatment of relapsed or refractory lymphoma or clonal cytopenia of undetermined significance","year":"2018"},{"key":"B142","volume-title":"A phase Ib\/IIa study evaluating the safety and tolerability of vitamin c in patients with intermediate or high risk myelodysplastic syndrome with TET2 mutations","year":"2018"},{"key":"B143","volume-title":"High dose ascorbate with preoperative radiation in patients with locally advanced soft tissue sarcomas","year":"2018"},{"key":"B144","volume-title":"Epigenetics, vitamin c, and abnormal blood cell formation - vitamin c in patients with low-risk myeloid malignancies","year":"2018"},{"key":"B145","volume-title":"Vitamin c and tyrosine kinase inhibitor in lung cancer patients with epidermal growth factor receptor mutations","year":"2019"},{"key":"B146","volume-title":"Combining active and passive DNA hypomethylation","year":"2019"},{"key":"B147","volume-title":"High dose vitamin c combined with metformin in the treatment of malignant tumors","year":"2019"},{"key":"B148","volume-title":"Intravenous (IV) vitamin c with chemotherapy for cisplatin ineligible bladder cancer patients","year":"2019"},{"key":"B149","volume-title":"IV ascorbic acid in peritoneal metastatic colorectal cancer","year":"2020"},{"key":"B150","volume-title":"Gemcitabine plus ascorbate for sarcoma in adults (Pilot)","year":"2020"},{"key":"B151","volume-title":"Preoperative IMRT with concurrent high-dose vitamin c and mFOLFOX6 in locally advanced rectal cancer","year":"2021"},{"key":"B152","volume-title":"Docetaxel with or without ascorbic acid in treating patients with metastatic prostate cancer","year":"2022"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2003.10719284","article-title":"The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer","volume":"22","author":"Drisko","year":"2003","journal-title":"J Am Coll Nutr"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/ICST.1000219","article-title":"High dose intravenous vitamin c and metastatic pancreatic cancer: two cases","volume":"3","author":"Gonz\u00e1lez","year":"2016","journal-title":"Integr Cancer Sci Ther"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050346","article-title":"Intravenously administered vitamin c as cancer therapy: three cases","volume":"174","author":"Padayatty","year":"2006","journal-title":"CMAJ"},{"key":"B156","article-title":"Intravenous vitamin c as a chemotherapy agent: a report on clinical cases","volume":"23","author":"Riordan","year":"2004","journal-title":"P R Health Sci J"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2015.56.5.1449","article-title":"High-dose vitamin c promotes regression of multiple pulmonary metastases originating from hepatocellular carcinoma","volume":"56","author":"Seo","year":"2015","journal-title":"Yonsei Med J"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000603","article-title":"Treatment of pancreatic cancer with intravenous vitamin c: a case report","volume":"29","author":"Drisko","year":"2018","journal-title":"Anticancer Drugs"},{"key":"B159","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ccell.2017.02.018","article-title":"O2\u00b7- and H2O2-mediated disruption of fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate","volume":"31","author":"Schoenfeld","year":"2017","journal-title":"Cancer Cell"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2017.12.009","article-title":"The synergy of vitamin c with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia","volume":"66","author":"Zhao","year":"2018","journal-title":"Leuk Res"},{"key":"B161","article-title":"Intravenous vitamin c administration improves quality of life in breast cancer patients during chemo-\/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany","volume":"25","author":"Vollbracht","year":"2011","journal-title":"In Vivo"},{"key":"B162","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pmu.2012.05.008","article-title":"High-dose intravenous vitamin c improves quality of life in cancer patients","volume":"1","author":"Takahashi","year":"2012","journal-title":"Pers Med Univ"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0381","article-title":"Is there a role for oral or intravenous ascorbate (vitamin c) in treating patients with cancer? a systematic review","volume":"20","author":"Jacobs","year":"2015","journal-title":"Oncologist"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081208","article-title":"Antioxidant defenses: A context-specific vulnerability of cancer cells","volume":"11","author":"Cockfield","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03549-5","article-title":"Cross-tissue organization of the fibroblast lineage","volume":"593","author":"Buechler","year":"2021","journal-title":"Nature"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1658","article-title":"Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells","volume":"9","author":"Gaggioli","year":"2007","journal-title":"Nat Cell Biol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10204","article-title":"Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts","volume":"6","author":"Albrengues","year":"2015","journal-title":"Nat Commun"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1007\/BF03187139","article-title":"Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma","volume":"1","author":"Nathanson","year":"1994","journal-title":"Ann Surg Oncol"},{"key":"B170","first-page":"1","article-title":"Tumor invasion and metastases\u2013role of the extracellular matrix: Rhoads memorial award lecture","volume":"46","author":"Liotta","year":"1986","journal-title":"Cancer Res"},{"key":"B171","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ceb.2010.08.015","article-title":"Dynamic interplay between the collagen scaffold and tumor evolution","volume":"22","author":"Egeblad","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092256","article-title":"Activated fibroblast program orchestrates tumor initiation and progression; molecular mechanisms and the associated therapeutic strategies","volume":"20","author":"Yoshida","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B174","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic reprogramming: the emerging concept and associated therapeutic strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16556","article-title":"HIF-1\u03b1 is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer","volume":"25","author":"Zhang","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.02.006","article-title":"Metabolic reprogramming of cancer-associated fibroblasts by IDH3\u03b1 downregulation","volume":"10","author":"Zhang","year":"2015","journal-title":"Cell Rep"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.06.018","article-title":"ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma","volume":"20","author":"Sanz-Moreno","year":"2011","journal-title":"Cancer Cell"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107701","article-title":"Epigenetic reprogramming of cancer-associated fibroblasts deregulates glucose metabolism and facilitates progression of breast cancer","volume":"31","author":"Becker","year":"2020","journal-title":"Cell Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.981547\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T06:15:29Z","timestamp":1663654529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.981547\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":178,"alternative-id":["10.3389\/fonc.2022.981547"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.981547","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"article-number":"981547"}}